Saradna Arjun, Do Danh C, Kumar Shruthi, Fu Qing-Ling, Gao Peisong
Division Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md; Department of Internal Medicine, Maimonides Medical Center, Brooklyn, NY.
Division Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Md.
Transl Res. 2018 Jan;191:1-14. doi: 10.1016/j.trsl.2017.09.002. Epub 2017 Oct 7.
Allergic asthma is associated with airway inflammation and airway hyperresponsiveness. Macrophage polarization has been shown to have a profound impact on asthma pathogenesis. On exposure to local microenvironments, recruited macrophages can be polarized into either classically activated (or M1) or alternatively activated (or M2) phenotypes. Macrophage polarization has been heavily associated with development of asthma. The process of regulation of macrophage polarization involves an intricate interplay between various cytokines, chemokines, transcriptional factors, and immune-regulatory cells. Different signals from the microenvironment are controlled by different receptors on the macrophages to initiate various macrophage polarization pathways. Most importantly, there is an increased attention on the epigenetic changes (eg, microRNAs, DNA methylation, and histone modification) that impact macrophage functional responses and M1/M2 polarization through modulating cellular signaling and signature gene expression. Thus, modulation of macrophage phenotypes through molecular intervention by targeting some of those potential macrophage regulators may have therapeutic potential in the treatment of allergic asthma and other allergic diseases. In this review, we will discuss the origin of macrophages, characterization of macrophages, macrophage polarization in asthma, and the underlying mechanisms regarding allergen-induced macrophage polarization with emphasis on the regulation of epigenetics, which will provide new insights into the therapeutic strategy for asthma.
过敏性哮喘与气道炎症和气道高反应性相关。巨噬细胞极化已被证明对哮喘发病机制有深远影响。在接触局部微环境时,募集到的巨噬细胞可极化为经典活化(或M1)或替代活化(或M2)表型。巨噬细胞极化与哮喘的发展密切相关。巨噬细胞极化的调节过程涉及多种细胞因子、趋化因子、转录因子和免疫调节细胞之间复杂的相互作用。巨噬细胞上的不同受体控制来自微环境的不同信号,以启动各种巨噬细胞极化途径。最重要的是,人们越来越关注表观遗传变化(如微小RNA、DNA甲基化和组蛋白修饰),这些变化通过调节细胞信号传导和特征基因表达来影响巨噬细胞功能反应和M1/M2极化。因此,通过靶向一些潜在的巨噬细胞调节因子进行分子干预来调节巨噬细胞表型,可能在过敏性哮喘和其他过敏性疾病的治疗中具有治疗潜力。在本综述中,我们将讨论巨噬细胞的起源、巨噬细胞的特征、哮喘中的巨噬细胞极化以及变应原诱导巨噬细胞极化的潜在机制,重点是表观遗传学的调节,这将为哮喘的治疗策略提供新的见解。